Like many trade shows, conferences and other events this year, the American Society of Gene & Cell Therapy (ASGCT) had to quickly make alternative arrangements for its annual meeting due to COVID-19. To avoid cancelling this highly anticipated event, organizers opted for a virtual conference for speakers, exhibitors and attendees.

Starting out, Aldevron founders Michael Chambers and John Ballantyne had one thing in common besides being fascinated with biotechnology and its applications in health care. They are both graduates of North Dakota State University (NDSU) in Fargo.